Neutral Bill Mar 16, 2026

Corporate Income Tax - Addition Modification - Direct-to-Consumer Pharmaceutical Advertising

Providing an addition modification under the corporate income tax for the amount of certain direct-to-consumer advertising expenses for certain covered drugs paid or incurred during the taxable year that are deducted under the Internal Revenue Code; and applying the Act to all taxable years beginning after December 31, 2025.

https://legiscan.com/MD/bill/HB484/2026

Natalie Ziegler Delegate Jessica Feldmark Delegate Cosponsor Lorig Charkoudian Delegate Cosponsor Eric Ebersole Delegate Cosponsor Pam Guzzone Delegate Cosponsor Terri Hill Delegate Cosponsor Courtney Watson Delegate Cosponsor

Postal service Income tax CORPORATIONS ADVERTISING INTERNET DRUGS Exemptions Public Health Social Media Telecommunications Mobile Devices Taxes - Income Electronic Communication Telephones Signs and Billboards Industry and Manufacturing Commerce and Business Radio Television

← Back to Natalie Ziegler's profile